Basic Information
RNALocate ID: | RLID:02000506 |
RNA Symbol: | MALAT1 |
Localization: | Nucleus |
RNA Information
RNA Name: | MALAT1 |
RNA ID: | NCBI:378938|Ensembl:ENSG00000251562 |
RNA Category: | lncRNA |
Species: | Homo sapiens |
Alias: | HCN|LINC00047|NCRNA00047|NEAT2|PRO2853 |
Localization Information
PubMed ID: | 28663102 |
Tissue/Cell Line: | HeLa cells |
Method: | qRT-PCR |
Next, qRT-PCR analyses were performed to detect the levels and subcellular distribution of mature and pre-mRNAs for the untargeted SOD1 (Figure 4F) and targeted NCL1 (Figure 4G), Ago2 (Figure 4H), and MALAT1 lncRNA (Figure 4I). Originally published in Mol Ther. Liang XH, et al, 2017. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | To assess the rates of mRNA loss in the presence or absence of ASOs, we transfected HeLa cells with ASOs targeting nuclear RNAs (U16 snoRNA and MALAT1 lncRNA) or the exonic regions of cytoplasmic mRNAs (NCL1 and Drosha). ASO treatment was performed for different times, and total RNA was prepared and subjected to qRT-PCR analyses to determine the levels of the targeted RNAs. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:02000386 | Nucleus | ZFL cells | 28538188 |
RLID:02000501 | Chromatin | Breast cancer cell line (SKBR3) | 28652379 |
RLID:02000502 | Cytoplasm | HEK-293T cells|Mammary epithelium cell line (HC11) | 31863590 |
RLID:02000503 | Cytosol | Human myelogenous leukemia cell line (K-562) | 21613539 |
RLID:02000504 | Mitochondrion | HCC cell line (HepG2) | 31218107 |
RLID:02000505 | Nucleus | Human osteosarcoma cell line (U2OS) | 28423669 |
RLID:02000507 | Nucleus | WI-38 cells | 29133588 |
RLID:02000508 | Nucleus | Human brain microvascular endothelial cells | 30419554 |
RLID:02000509 | Nuclear speckle | Breast cancer cell line (MCF-7) | 28652379 |
RLID:02000510 | Nuclear speckle | Retinal microvascular endothelial cells | 30815547 |
RLID:02000511 | Nuclear speckle | U2OS cells | 31085639 |
RLID:02000512 | Nuclear speckle | HEK-293T cells|Mammary epithelium cell line (HC11) | 31863590 |
RLID:02000513 | Nuclear speckle | HeLa-TO cells | 22355166 |
RLID:02000514 | Nucleoplasm | WI-38 cells | 29133588 |
RLID:02000515 | Nucleus | Human cervical cancer cell line (HeLa) | 28216671 |
RLID:02000516 | Nucleus | U2OS cells | 28538188 |
RLID:02000517 | Nucleus | Breast cancer cell lines (MDA-MB-468|SKBR3) | 28652379 |
RLID:02000518 | Nucleus | HeLa cells | 29335281 |
RLID:02000519 | Nucleus | Lung cancer cell line (A549) | 30548064 |
RLID:02000520 | Nucleus | Vascular smooth muscle cells | 31696492 |
RLID:02000521 | Nucleus | Fibroblasts|Lymphoblasts | 17270048 |
RLID:02000522 | Nucleus | Cell line (HeLa) | 19041754 |
RLID:02000523 | Nucleus | HeLa cells | 20797886 |
RLID:02000524 | Nucleus | Motor neurons | 22070123 |
RLID:02000525 | Nucleus | Human cervical cancer cell line (HeLa) | 22078878 |
RLID:02000526 | Nucleus | CLTon cells | 22855529 |
RLID:02000527 | Nucleus | HeLa cells | 23073843 |
RLID:02000528 | Nucleus | Cell line (HeLa) | 23152763 |
RLID:02000529 | Nucleus | Colon cancer cells | 24393600 |
RLID:02000530 | Nucleus | HeLa cells | 25630241 |
RLID:02001011 | Nucleus | IgH-2 cells|Periphery of seminiferous tubules | 28538188 |
RLID:02001145 | Cytoplasm | Lung cancer cell lines (A549|H1299) | 34012919 |
RLID:12000064 | Exosome | Thyroid papillary carcinoma cell line (TPC-1) | 29967342 |
RLID:12000065 | Exosome | HeLa cells | 24205503 |
RLID:22000052 | Speckle periphery | HeLa cells|WI-38 cells | 29133588 |
RLID-D:02000317 | Chromatin | HeLa-S3 cells|K562 cells | |
RLID-D:02000618 | Cytosol | HCC cell line (HepG2)|HeLa-S3 cells|K562 cells | |
RLID-D:02000717 | Insoluble cytoplasm | K562 cells | |
RLID-D:02000824 | Membrane | HCC cell line (HepG2)|K562 cells | |
RLID-D:02001085 | Nucleolus | K562 cells | |
RLID-D:02001487 | Nucleoplasm | K562 cells | |
RLID-D:02002025 | Nucleus | HCC cell line (HepG2)|HeLa-S3 cells|K562 cells | |
RLID-D:12004468 | Exosome | Serum |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | MALAT1 | Anaplastic large cell lymphoma | MNDR-E-LNC-17626 |
MNDR | MALAT1 | Diffuse large b cell lymphoma | MNDR-E-LNC-17627 |
MNDR | MALAT1 | Mantle cell lymphoma | MNDR-E-LNC-17628 |
MNDR | MALAT1 | Oral tongue squamous cell carcinoma | MNDR-E-LNC-17629 |
MNDR | MALAT1 | Oral squamous cell carcinoma | MNDR-E-LNC-17630 |
MNDR | MALAT1 | Fibroma | MNDR-E-LNC-17631 |
MNDR | MALAT1 | Triple negative breast cancer | MNDR-E-LNC-17632 |
MNDR | MALAT1 | Nonalcoholic fatty liver disease | MNDR-E-LNC-17633 |
MNDR | MALAT1 | Anaplastic thyroid cancer | MNDR-E-LNC-17634 |
MNDR | MALAT1 | Prostate cancer | MNDR-E-LNC-17635 |
MNDR | MALAT1 | Silicosis | MNDR-E-LNC-17636 |
MNDR | MALAT1 | Chronic lymphocytic leukemia | MNDR-E-LNC-17637 |
MNDR | MALAT1 | Gastric cancer | MNDR-E-LNC-17638 |
MNDR | MALAT1 | Pre-eclampsia | MNDR-E-LNC-17639 |
MNDR | MALAT1 | Alzheimer disease | MNDR-E-LNC-17640 |
MNDR | MALAT1 | Bladder cancer | MNDR-E-LNC-17641 |
MNDR | MALAT1 | Gestational diabetes | MNDR-E-LNC-17642 |
MNDR | MALAT1 | Seizures | MNDR-E-LNC-17643 |
MNDR | MALAT1 | Lung cancer | MNDR-E-LNC-17644 |
MNDR | MALAT1 | Diabetic cataract | MNDR-E-LNC-17645 |
MNDR | MALAT1 | Parkinson disease | MNDR-E-LNC-17646 |
MNDR | MALAT1 | Primary pulmonary hypertension | MNDR-E-LNC-17647 |
MNDR | MALAT1 | Breast cancer | MNDR-E-LNC-17648 |
MNDR | MALAT1 | Cancer | MNDR-E-LNC-17649 |
MNDR | MALAT1 | Squamous cell carcinoma | MNDR-E-LNC-17650 |
MNDR | MALAT1 | Thyroid cancer | MNDR-E-LNC-17651 |
MNDR | MALAT1 | Pancreatic cancer | MNDR-E-LNC-17652 |
MNDR | MALAT1 | Malignant melanoma | MNDR-E-LNC-17653 |
MNDR | MALAT1 | Atherosclerosis | MNDR-E-LNC-17654 |
MNDR | MALAT1 | Vulva squamous cell carcinoma | MNDR-E-LNC-17655 |
MNDR | MALAT1 | Epithelial ovarian cancer | MNDR-E-LNC-17656 |
MNDR | MALAT1 | Colon cancer | MNDR-E-LNC-17657 |
MNDR | MALAT1 | Hepatitis | MNDR-E-LNC-17658 |
MNDR | MALAT1 | Ovarian cancer | MNDR-E-LNC-17659 |
MNDR | MALAT1 | Laryngeal and hypopharyngeal carcinoma | MNDR-E-LNC-17660 |
MNDR | MALAT1 | Kidney cancer | MNDR-E-LNC-17661 |
MNDR | MALAT1 | Urothelial cancer | MNDR-E-LNC-17662 |
MNDR | MALAT1 | Infantile hemangioma | MNDR-E-LNC-17663 |
MNDR | MALAT1 | Carcinoma endometrioid | MNDR-E-LNC-17664 |
MNDR | MALAT1 | Endometrial carcinoma | MNDR-E-LNC-17665 |
MNDR | MALAT1 | Laryngeal squamous cell cancer | MNDR-E-LNC-17666 |
MNDR | MALAT1 | Endometriosis | MNDR-E-LNC-17667 |
MNDR | MALAT1 | DH1/2 wild-type primary GB tumor | MNDR-E-LNC-17668 |
MNDR | MALAT1 | Astrocytoma | MNDR-E-LNC-17669 |
MNDR | MALAT1 | Glioma | MNDR-E-LNC-17670 |
MNDR | MALAT1 | Gastrointestinal system cancer | MNDR-E-LNC-17671 |
MNDR | MALAT1 | Gallbladder cancer | MNDR-E-LNC-17672 |
MNDR | MALAT1 | Skin squamous cell carcinoma | MNDR-E-LNC-17673 |
MNDR | MALAT1 | Amyotrophic lateral sclerosis | MNDR-E-LNC-17674 |
MNDR | MALAT1 | Osteosarcoma | MNDR-E-LNC-17675 |
MNDR | MALAT1 | Fibrosarcoma | MNDR-E-LNC-17676 |
MNDR | MALAT1 | Ewing sarcoma | MNDR-E-LNC-17677 |
MNDR | MALAT1 | Pancreatic ductal adenocarcinoma | MNDR-E-LNC-17678 |
MNDR | MALAT1 | Liver cancer | MNDR-E-LNC-17679 |
MNDR | MALAT1 | Choriocarcinoma | MNDR-E-LNC-17680 |
MNDR | MALAT1 | Uterine cancer | MNDR-E-LNC-17681 |
MNDR | MALAT1 | Gastric adenocarcinoma | MNDR-E-LNC-17682 |
MNDR | MALAT1 | Esophagus squamous cell carcinoma | MNDR-E-LNC-17683 |
MNDR | MALAT1 | Pulmonary fibrosis | MNDR-E-LNC-17684 |
MNDR | MALAT1 | Pituitary adenoma | MNDR-E-LNC-17685 |
MNDR | MALAT1 | Lung squamous cell carcinoma | MNDR-E-LNC-17686 |
MNDR | MALAT1 | Carcinoma lung non-small-cell | MNDR-E-LNC-17687 |
MNDR | MALAT1 | Lung adenocarcinoma | MNDR-E-LNC-17688 |
MNDR | MALAT1 | Adrenocortical carcinoma | MNDR-E-LNC-17689 |
MNDR | MALAT1 | Follicular thyroid carcinoma | MNDR-E-LNC-17690 |
MNDR | MALAT1 | Papillary thyroid cancer | MNDR-E-LNC-17691 |
MNDR | MALAT1 | Medullary thyroid carcinoma | MNDR-E-LNC-17692 |
MNDR | MALAT1 | Thyroid medullary carcinoma | MNDR-E-LNC-17693 |
MNDR | MALAT1 | Ovarian carcinoma | MNDR-E-LNC-17694 |
MNDR | MALAT1 | Bladder urothelial carcinoma | MNDR-E-LNC-17695 |
MNDR | MALAT1 | Bladder carcinoma | MNDR-E-LNC-17696 |
MNDR | MALAT1 | Hyperglycemia | MNDR-E-LNC-17697 |
MNDR | MALAT1 | Endometrial stromal sarcoma | MNDR-E-LNC-17698 |
MNDR | MALAT1 | Uterine corpus endometrial stromal sarcoma | MNDR-E-LNC-17699 |
MNDR | MALAT1 | Cervical cancer | MNDR-E-LNC-17700 |
MNDR | MALAT1 | Renal cell carcinoma | MNDR-E-LNC-17701 |
MNDR | MALAT1 | Clear cell renal cell carcinoma | MNDR-E-LNC-17702 |
MNDR | MALAT1 | Histiocytoid hemangioma | MNDR-E-LNC-17703 |
MNDR | MALAT1 | Gorham's disease | MNDR-E-LNC-17704 |
MNDR | MALAT1 | Pancreatic carcinoma | MNDR-E-LNC-17705 |
MNDR | MALAT1 | Hilar cholangiocarcinoma | MNDR-E-LNC-17706 |
MNDR | MALAT1 | Cholangiocarcinoma | MNDR-E-LNC-17707 |
MNDR | MALAT1 | Esophageal cancer | MNDR-E-LNC-17708 |
MNDR | MALAT1 | Liver cirrhosis | MNDR-E-LNC-17709 |
MNDR | MALAT1 | HIV | MNDR-E-LNC-17710 |
MNDR | MALAT1 | Lung small cell carcinoma | MNDR-E-LNC-17711 |
MNDR | MALAT1 | Head and neck squamous cell carcinoma | MNDR-E-LNC-17712 |
MNDR | MALAT1 | Kidney diseases | MNDR-E-LNC-17713 |
MNDR | MALAT1 | Myocardial infarction | MNDR-E-LNC-17714 |
MNDR | MALAT1 | Uveal melanoma | MNDR-E-LNC-17715 |
MNDR | MALAT1 | Aortic valve disease | MNDR-E-LNC-17716 |
MNDR | MALAT1 | Ovarian endometrial cancer | MNDR-E-LNC-17717 |
MNDR | MALAT1 | Acute monocytic leukemia | MNDR-E-LNC-17718 |
MNDR | MALAT1 | Bladder transitional cell carcinoma | MNDR-E-LNC-17719 |
MNDR | MALAT1 | Ischemic stroke | MNDR-E-LNC-17720 |
MNDR | MALAT1 | Endometrioid endometrial cancer | MNDR-E-LNC-17721 |
MNDR | MALAT1 | Hepatocellular carcinoma | MNDR-E-LNC-17722 |
MNDR | MALAT1 | Hepatoblastoma | MNDR-E-LNC-17723 |
MNDR | MALAT1 | B-cell lymphoma | MNDR-E-LNC-17724 |
MNDR | MALAT1 | Rheumatoid arthritis | MNDR-E-LNC-17725 |
MNDR | MALAT1 | Retinoblastoma | MNDR-E-LNC-17726 |
MNDR | MALAT1 | Neuroblastoma | MNDR-E-LNC-17727 |
MNDR | MALAT1 | Osteoarthritis | MNDR-E-LNC-17728 |
MNDR | MALAT1 | Retinal degeneration | MNDR-E-LNC-17729 |
MNDR | MALAT1 | Monocytic leukemia | MNDR-E-LNC-17730 |
MNDR | MALAT1 | Chronic myeloid leukemia | MNDR-E-LNC-17731 |
MNDR | MALAT1 | Tongue cancer | MNDR-E-LNC-17732 |
MNDR | MALAT1 | Diabetic retinopathy | MNDR-E-LNC-17733 |
MNDR | MALAT1 | Systemic lupus erythematosus | MNDR-E-LNC-17734 |
MNDR | MALAT1 | Acute myeloid leukemia | MNDR-E-LNC-17735 |
MNDR | MALAT1 | Colorectal cancer | MNDR-E-LNC-17736 |
MNDR | MALAT1 | Nasopharyngeal carcinoma | MNDR-E-LNC-17737 |
MNDR | MALAT1 | Nasopharynx carcinoma | MNDR-E-LNC-17738 |
MNDR | MALAT1 | Diabetes mellitus | MNDR-E-LNC-17739 |
MNDR | MALAT1 | Type 2 diabetes mellitus | MNDR-E-LNC-17740 |
MNDR | MALAT1 | Acute myocardial infarction | MNDR-E-LNC-17741 |
MNDR | MALAT1 | Fatty liver disease | MNDR-E-LNC-17742 |
MNDR | MALAT1 | Multiple myeloma | MNDR-E-LNC-17743 |
MNDR | MALAT1 | Extramedullary myeloma | MNDR-E-LNC-17744 |
MNDR | MALAT1 | Proliferative vitreoretinopathy | MNDR-E-LNC-17745 |
MNDR | MALAT1 | TDP-43 protein human | MNDR-E-LNC-17746 |
MNDR | MALAT1 | Aortic valve calcification | MNDR-E-LNC-17747 |
MNDR | MALAT1 | Ovarian epithelial cancer | MNDR-E-LNC-17748 |
MNDR | MALAT1 | Esophageal squamous cancer | MNDR-E-LNC-17749 |
MNDR | MALAT1 | Bronchopulmonary dysplasia | MNDR-E-LNC-17750 |
MNDR | MALAT1 | Uterine cervical neoplasms | MNDR-E-LNC-17751 |
MNDR | MALAT1 | Diabetic nephropathies | MNDR-E-LNC-17752 |
MNDR | MALAT1 | Nasopharyngeal cancer | MNDR-E-LNC-17753 |
MNDR | MALAT1 | Prostate | MNDR-E-LNC-17754 |
MNDR | MALAT1 | Spinal cord injury | MNDR-E-LNC-17755 |
MNDR | MALAT1 | Flavivirus infections | MNDR-E-LNC-17756 |
MNDR | MALAT1 | Sepsis | MNDR-E-LNC-17757 |
MNDR | MALAT1 | Nk/t cell lymphoma | MNDR-E-LNC-17758 |
MNDR | MALAT1 | Acute lung injury | MNDR-E-LNC-17759 |
MNDR | MALAT1 | Diabetic cardiomyopathies | MNDR-E-LNC-17760 |
MNDR | MALAT1 | Congenital microtia | MNDR-E-LNC-17761 |
MNDR | MALAT1 | Calcific aortic valve disease | MNDR-E-LNC-17762 |
MNDR | MALAT1 | Cardiomyocyte apoptosis | MNDR-E-LNC-17763 |
MNDR | MALAT1 | Cerebral ischemia-reperfusion injury | MNDR-E-LNC-17764 |
MNDR | MALAT1 | Cutaneous squamous cell carcinoma | MNDR-E-LNC-17765 |
MNDR | MALAT1 | Decreased myogenesis | MNDR-E-LNC-17766 |
MNDR | MALAT1 | EndMT-related diseases | MNDR-E-LNC-17767 |
MNDR | MALAT1 | High glucose-induced podocyte injury | MNDR-E-LNC-17768 |
MNDR | MALAT1 | Lymph node metastasis | MNDR-E-LNC-17769 |
MNDR | MALAT1 | Photo-aging | MNDR-E-LNC-17770 |
MNDR | MALAT1 | Plexiform fibromyxoma | MNDR-E-LNC-17771 |
MNDR | MALAT1 | Renal ischemia-reperfusion injury | MNDR-E-LNC-17772 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCA1 | Homo sapiens | RR00022040 |
TOP